Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Patient-specific 3D-printed breast molds for shaping tissue during autologous reconstruction

Official title: Interactive Design of Patient-Specific Molds for Tissue Shaping

Run by M.D. Anderson Cancer Center · NCT06711965 · Data updated 2026-11-12

This project will test whether 3D-printed, patient-specific breast molds help surgeons shape tissue faster and more consistently during autologous breast reconstruction for adults after mastectomy.

More Mastectomy trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment160 (estimated)
SponsorM.D. Anderson Cancer Center
Academic / other
Drugs / interventionsradiation
Locations1 site (Houston, Texas)
StatusRecruiting
StartedMarch 2, 2026
Main results expectedAugust 1, 2028
Study endsAugust 1, 2030
Registry record updatedOctober 6, 2026
Trial IDNCT06711965 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) who can provide informed consent and are scheduled for autologous breast reconstruction using DIEP or TRAM free flaps are ideal candidates.

Probably not a fit

Patients planned for stacked flaps, DIEP with vascularized lymph node transfer, those receiving neoadjuvant radiation, or patients undergoing implant-based reconstruction are unlikely to benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Surgeons will use clinical decision-support algorithms to design patient-specific breast molds that are produced with 3D printing and used intraoperatively during autologous free-flap reconstruction (DIEP or TRAM). Participants will be enrolled into intervention and control groups to compare outcomes with and without the custom mold. The primary outcome focuses on operative efficiency for tissue shaping, while secondary outcomes include number of mold uses, intraoperative shaping time, aesthetic revision rates, and postoperative complications. Results will inform the practical utility of the algorithms and molds for routine reconstructive practice.

Why it matters

Potential benefit: If successful, patient-specific molds could shorten operative time and improve cosmetic results after autologous breast reconstruction.

How similar studies have gone: Prior case series and small studies using 3D-printed templates or surgical guides in breast and reconstructive surgery have shown promising feasibility and aesthetic improvements, but randomized data are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patients 18 years of age or older
2. Patients who are willing and able to provide informed consent
3. Patients who are scheduled to undergo breast reconstruction with free flap (Deep Interior Epigastric Artery Perforator (DIEP) flap or Transverse Rectus Abdominis Myocutaneous (TRAM) flap)

Exclusion Criteria:

1. Patients whose surgical plan includes the use of stacked flaps (DIEP + other free flap, usually from the thigh or buttock)
2. Patients whose surgical plan includes the use of DIEP flap with vascularized lymph node transfer
3. Patients undergoing neoadjuvant radiation

Where it's running

  • The University of Texas M. D. Anderson Cancer Center
    Houston, Texas, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.